Harbin Chaoqun Hechuang Biotechnology Co., Ltd. is a high-tech industrial technology company engaged in biotechnology research and development, genetic engineering technology and biochemical product technology research and development, biological feed research and development, fermentation process optimization technology research and development, and emerging energy technology research and development. The company was registered and established on March 16, 2021, with a registered capital of 100 million yuan. The company has an international technology team that has been engaged in research and development in the fields of biology, nutrition science, medicine, etc. for many years, achieving remarkable results and possessing multiple technical patents and achievements. The company has 50 technical personnel, including 40 professional technical personnel with bachelor's degrees or above, and 4 doctoral and foreign experts, who are responsible for enterprise management, product research and development, process technology, production and processing, inspection and analysis, etc. The process technology for extracting 25 hydroxyvitamin D3 feed additive by biological method is superior to the international level and is the first of its kind in China. The product has obtained the EU FAMI-QS certification. The world's first 25 hydroxyvitamin D3 product applied to the human body is about to enter the market.